Star And Portfolio Firm Electra Roll Out With Focus On Rare Immunologic Disease

 
• By Joseph Haas
  
Star Feature Image
Star and its portfolio companies will seek novel therapies for multiple indications • Source: Alamy

More from Financing

More from Business